Similar Papers

Paper Title
Journal
Date
Author
Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases
Claire M Rice ... Neil J Scolding
The Lancet | VOL. 382
Claire M Rice, et. al.Claire M Rice ... Neil J Scolding
01 Oct 2013
P031 - Mesenchymal stem cell therapy in multiple sclerosis: An updated review of the current clinical trials
O Mirmosayyeb ... V Shaygannejad
Multiple Sclerosis and Related Disorders | VOL. 3
O Mirmosayyeb, et. al.O Mirmosayyeb ... V Shaygannejad
01 Nov 2014
Adult stem cells and multiple sclerosis
N Scolding
Cell Proliferation | VOL. 44
N ScoldingN Scolding
01 Apr 2011
Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein-Barr Virus-Specific T Cell Therapy.
Zara A Ioannides ... Nanette L Douglas
Frontiers in Neurology | VOL. 12
Zara A Ioannides, et. al.Zara A Ioannides ... Nanette L Douglas
15 Mar 2021
View more papers

More From: Meditsinskiy sovet = Medical Council

Paper Title
Journal
Date
Author
The possibilities of assessing regional risk factors for lung cancer
S V Kapralov ... O M Konopatskova
Meditsinskiy sovet = Medical Council | VOL. -
S V Kapralov, et. al.S V Kapralov ... O M Konopatskova
23 Dec 2024
A clinical case of the effectiveness of the anti PD-1 inhibitor (prolgolimab) in the treatment of metastatic melanoma
P V Golubev ... V N Galkin
Meditsinskiy sovet = Medical Council | VOL. -
P V Golubev, et. al.P V Golubev ... V N Galkin
23 Dec 2024
Experience with perioperative drug therapy in patients with stage III non-small cell lung cancer (results of the observational study CARL-001)
K K Laktionov ... I V Plokhotenko
Meditsinskiy sovet = Medical Council | VOL. -
K K Laktionov, et. al.K K Laktionov ... I V Plokhotenko
23 Dec 2024
Non-small cell lung cancer with MET mutation: a clinical case of treatment with MET inhibitor capmatinib
K V Menshikov ... Sh N Galimov
Meditsinskiy sovet = Medical Council | VOL. -
K V Menshikov, et. al.K V Menshikov ... Sh N Galimov
23 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.